Nkarta Inc at Jefferies Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. My name is Kelly Shi, one of the biotech equity analysts at Jefferies. Thank you for attending our Virtual Healthcare Conference. We are very pleased to have Mr. Paul Hastings, President and CEO from Nkarta Therapeutics, join us today. He also brings his big team, Kanya, Ralph, Nadir, James and Greg.
And to start off, Paul, could you introduce your team and also the company for those who are less familiar with the Nkarta story?
Yes. Thank you, Kelly, for inviting us. And we're thrilled to be here. The beauty of Zoom is you have the whole team. So you can ask whatever questions you'd like, Kelly. And we will be happy to give you multiple points of view on that one question you ask. So the team here, we have James, our CSO, Chief Scientific Officer; Kanya Rajangam is our Chief Medical Officer. Nadir Mahmood is our Chief Financial and Business Officer. And Ralph Brandenberger is our Senior VP of Tech Ops
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |